The DC District Court rules in FDAs favor to dismiss a suit by the Center for Responsible Science that sought new warnings on informed consent documen...
FDA releases the FDA-483 with four observations issued following an inspection at the QuVa Pharma drug outsourcing facility in Temple, TX.
FDA tells members of two advisory committees that InfaCares stannsoporfin appears to be effective in treating hyperbilirubinemia but may be associated...
National Public Radio says FDA approved Innovative Health Solutions Bridge medical device for use in opioid withdrawal based on a study that was misre...
FDA grants Bavarian Nordic an orphan drug designation for its BN-Brachyury vaccine for treating chordoma, a rare cancer that develops along the spine.
FDA approves Bausch + Lombs Ultra contact lenses for extended wear for up to six nights and seven days of continuous wear.
Biocon says an FDA-483 issued following an inspection at its Bangalore, India, sterile drug manufacturing facility has seven observations.
Fresenius says its decision last month to terminate the companys $4.7 billion merger agreement with generic drug company Akorn was based on alleged bl...